Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/18/1996 | EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
09/18/1996 | EP0731838A1 Binding structures directed against the ca55.1 antigen |
09/18/1996 | EP0731837A1 Bacteria used to produce stable fusion proteins and method for their identification |
09/18/1996 | EP0731836A1 Chicken oocyte receptor p95 (vldl/vtg receptor) |
09/18/1996 | EP0731835A1 Antisense oligonucleotides having tumorigenicity-inhibiting activity |
09/18/1996 | EP0731811A1 Chaperonin 10 |
09/18/1996 | EP0731809A1 Chirally enriched synthetic phosphonate oligomers |
09/18/1996 | EP0731808A1 Nucleosides and oligonucleotides containing boron clusters |
09/18/1996 | EP0731807A1 N-2 substituted purines |
09/18/1996 | EP0731806A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
09/18/1996 | EP0731709A1 Novel neutrophil inhibitors |
09/18/1996 | EP0731636A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
09/18/1996 | EP0731632A1 $i(AGROBACTERIUM TUMEFACIENS) TRANSFORMATION OF $i(MUSA) SPECIES |
09/18/1996 | EP0629244B1 Pathogen-targeted biocatalyst |
09/18/1996 | EP0527941B1 Identification of novel drugs and reagents |
09/18/1996 | EP0524958B1 Antigenic proteins of borrelia burgdorferi |
09/18/1996 | CN1131440A TAG reagent and assay method |
09/18/1996 | CN1131439A Chitinase DNA coding thereof and plants containing same |
09/18/1996 | CN1131438A Protein having TPO activity |
09/18/1996 | CN1131437A Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
09/18/1996 | CN1131194A Salmonella rDNA spacer nucleic acid molecular probe and its using method |
09/18/1996 | CN1131192A Recombinant mersacidin and method for production |
09/17/1996 | US5557032 Knockout mice |
09/17/1996 | US5556958 Aminopsoralens |
09/17/1996 | US5556956 Methods and compositions relating to the androgen receptor gene and uses thereof |
09/17/1996 | US5556954 Dna and rna for genetic engineering |
09/17/1996 | US5556953 Dna sequence with code, genetic engineering |
09/17/1996 | US5556947 Monoclonal antibody recognizing a surface molecule on a subset of antigen-stimulated T cells and on certain malignancies of T and B cell origin |
09/17/1996 | US5556946 Interleukin-2/viral antigen protein chimers |
09/17/1996 | US5556944 Immunoglobulin a binding protein |
09/17/1996 | US5556943 Cell adhesion protein, gene coding for the same, process for preparing the same and carrier onto which the same is immobilized |
09/17/1996 | US5556784 Bacillus thuringiensis isolates active against lepidopteran pests |
09/17/1996 | US5556782 Transformed mammalian cells capable of expressing cecropin b |
09/17/1996 | US5556781 DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses |
09/17/1996 | US5556780 Nucleic acid sequences, diagnosis and treatment of cardiovascular diseases |
09/17/1996 | US5556776 Dna fragments with polypeptides formed by culture of bacteria in sucrose |
09/17/1996 | US5556771 Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification |
09/17/1996 | US5556769 Coupled replication-translation methods and kits for protein synthesis |
09/17/1996 | US5556767 Polynucleotide encoding macrophage inflammatory protein γ |
09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
09/17/1996 | US5556754 Major histocompatibility complex, treatment of autoimmune diseases |
09/17/1996 | US5556753 DNA encoding human α1 adrenegric receptors and uses thereof |
09/17/1996 | US5556752 Solid supporrt with oligonucleotides, spacers, linking groups and double strands |
09/17/1996 | US5556750 Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems |
09/17/1996 | US5556749 Oligoprobe designstation: a computerized method for designing optimal DNA probes |
09/17/1996 | US5556747 Method for site-directed mutagenesis |
09/17/1996 | US5556746 Antibodies specific for the group antigen of astroviruses |
09/17/1996 | US5556621 Heat and acid resistant polypeptides or proteins as antiinflammatory agents |
09/17/1996 | US5556620 Colony stimulating factor for skin healing |
09/16/1996 | CA2171368A1 Recombinant dna virus and method for preparation thereof |
09/14/1996 | CA2171600A1 Dna molecules |
09/12/1996 | WO1996027681A1 Method of nucleic acid analysis |
09/12/1996 | WO1996027680A1 Sequence-specific detection of nucleic acids |
09/12/1996 | WO1996027679A1 Modulation of the binding properties of nucleic acid binding partners |
09/12/1996 | WO1996027677A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
09/12/1996 | WO1996027676A2 Method and means for the production of gene products, novel recombinant dna vectors therefor and kits employing them |
09/12/1996 | WO1996027675A1 Jellyfish green fluorescent protein (gfp) expression in plants |
09/12/1996 | WO1996027674A1 Modified starch from plants, plants synthesizing this starch, and process for its preparation |
09/12/1996 | WO1996027673A1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
09/12/1996 | WO1996027672A1 Latency active herpes virus promoters and their use to treat neurological lesions |
09/12/1996 | WO1996027671A1 Subtilisin variants capable of cleaving substrates containing basic residues |
09/12/1996 | WO1996027670A2 Enzymatic process for producing gdp-alpha-d-mannose, a gdp mannose pyrophosphorylase and phosphomannomutase suitable for that process, the extraction of the said enzymes, and an enzyme test |
09/12/1996 | WO1996027669A1 Process for producing trans-4-hydroxy-l-proline |
09/12/1996 | WO1996027668A1 PROCESS FOR PRODUCING cis-3-HYDROXY-L-PROLINE |
09/12/1996 | WO1996027667A1 Dna fragment encoding d-amino acid oxidase |
09/12/1996 | WO1996027666A1 Novel avian cytokines and genetic sequences encoding same |
09/12/1996 | WO1996027665A2 Neuron-restrictive silencer factor proteins |
09/12/1996 | WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
09/12/1996 | WO1996027663A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells |
09/12/1996 | WO1996027612A1 Production in yeasts of stable antibody fragments |
09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
09/12/1996 | WO1996027608A1 Process for producing a protein |
09/12/1996 | WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
09/12/1996 | WO1996027605A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |
09/12/1996 | WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders |
09/12/1996 | WO1996027432A1 Pressure cycling reactor |
09/12/1996 | WO1996027395A1 Gene-targeted non-human mammals deficient in the sod-1 gene |
09/12/1996 | WO1996027392A1 Antigen presenting system and methods for activation of t-cells |
09/12/1996 | WO1996027385A1 Anti-obesity proteins |
09/12/1996 | WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
09/12/1996 | WO1996022392A3 Nucleic acid amplification oligonucleotides and probes to lyme disease associated borrelia |
09/12/1996 | WO1996022380A3 Method to improve screening efficiency in fused cells |
09/12/1996 | WO1996021733A3 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy |
09/12/1996 | WO1996021022A3 Production of gamma linolenic acid by a δ6-desaturase |
09/12/1996 | WO1996021016A3 New staphylokinase derivatives |
09/12/1996 | WO1996018731A3 Isolation of nucleic acid |
09/12/1996 | WO1996003502A3 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer |
09/12/1996 | DE19509695A1 Verfahren zur Herstellung einer modifizieren Stärke in Pflanzen, sowie die aus den Pflanzen isolierbare modifizierte Stärke A process for producing a modified starch in plants, and the plants can be isolated from the modified starch |
09/12/1996 | DE19508290A1 Verfahren zur Kontrolle unerwünschter Virenvermehrung sowie zur Herstellung virusresistenter Organismen Method for controlling undesired viral replication and virus-resistant organisms for the production |
09/12/1996 | CA2214736A1 Modified starch from plants, plants synthesizing the same, as well as process for their production |
09/12/1996 | CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
09/12/1996 | CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders |
09/12/1996 | CA2214458A1 Enzymatic process for producing gdp-alpha-d-mannose, a gdp mannose pyrophosphorylase and phosphomannomutase suitable for that process, the extraction of the said enzymes, and an enzyme test |
09/12/1996 | CA2214453A1 Novel avian cytokines and genetic sequences encoding same |
09/12/1996 | CA2214430A1 Sequence-specific detection of nucleic acids |
09/12/1996 | CA2214283A1 Anti-obesity proteins |
09/12/1996 | CA2214271A1 Neuron-restrictive silencer factor proteins |
09/12/1996 | CA2214263A1 Pressure cycling reactor |
09/12/1996 | CA2212125A1 Process for producing a protein |
09/12/1996 | CA2209665A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |